|
Dishman Pharma & Chemicals Ltd. - Company Profile Snapshot
| Supplementary Analyses Reports |
| Financial Statement Analysis |
| Balance Sheet & Income Statement: |
| Common Size |
| Year To Year Percent Change |
| 5 Year Averages |
| Sources Of Capital |
| Financial Ratio Analysis |
| Accounting Ratios |
| Asset Utilization |
| Employee Efficiency |
| Fixed Charges Coverage |
| Leverage Analysis |
| Liquidity Analysis |
| Per Share Data |
| Profitability Analysis |
| Wright Quality Rating |
| Investment Acceptance |
| Financial Strength |
| Profitability & Stability |
| Corporate Growth |
 View sample Supplementary Analyses (PDF)
|
| Company Profile: |
Dishman Pharma & Chemicals Ltd. |
| Ticker: |
532526 |
| Exchanges: |
BOM |
| 2008 Sales: |
8,030,800,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Medical, Surgical & Dental Suppliers |
| Country: |
INDIA |
| Employees: |
778 |
Business Description
Dishman Pharma & Chemicals Ltd.. The Group's principal activity is the research and development of pharmaceutical and chemical products. It operates in two segments: Marketable Molecules segment and Contract Research and Contact Manufacturing segment. Marketable Molecules include basket of Quats, Specialty chemicals, Bulk actives and intermediates. Contact research segment includes manufacturing on behalf of the innovator/patent holder. The Group has offices in Europe and the United States.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
